Patents by Inventor Judit SOVAGO

Judit SOVAGO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220211679
    Abstract: The invention concerns the use of certain alpha 7 nicotinic acetylcholine receptor agonists for the treatment, amelioration, prevention or delay of progression of fatigue, narcolepsy, excessive daytime sleepiness, nocturnal sleep disturbance, and/or cataplexy.
    Type: Application
    Filed: March 21, 2022
    Publication date: July 7, 2022
    Inventors: Markus FENDT, Dominik FEUERBACH, Donald JOHNS, Cristina LOPEZ-LOPEZ, Kevin Hall MCALLISTER, Judit SOVAGO, Markus WEISS, Baltazar GOMEZ-MANCILLA
  • Patent number: 11369603
    Abstract: The invention relates to the use of a H3R inverse agonist for the treatment of shift work disorder.
    Type: Grant
    Filed: April 17, 2018
    Date of Patent: June 28, 2022
    Assignee: NOVARTIS AG
    Inventors: Donald Johns, Klaus Kucher, Judit Sovago
  • Publication number: 20220184073
    Abstract: The invention relates to the use of a H3R inverse agonist for the treatment of shift work disorder.
    Type: Application
    Filed: December 20, 2021
    Publication date: June 16, 2022
    Inventors: Donald JOHNS, Klaus KUCHER, Judit SOVAGO
  • Patent number: 11311525
    Abstract: The invention concerns the use of certain alpha 7 nicotinic acetylcholine receptor agonist for the facilitation of emergence from general anesthesia.
    Type: Grant
    Filed: August 25, 2017
    Date of Patent: April 26, 2022
    Assignee: Novartis AG
    Inventors: Markus Fendt, Dominik Feuerbach, Sjoerd Johannes Finnema, Christer Halldin, Donald Johns, Cristina Lopez-Lopez, Kevin Hall McAllister, Judit Sovago, Markus Weiss
  • Publication number: 20210379062
    Abstract: The invention relates to the use of Compound (I), as defined herein, or pharmaceutically acceptable salt thereof, in the treatment of excessive daytime sleepiness associated with Parkinson's disease.
    Type: Application
    Filed: October 10, 2019
    Publication date: December 9, 2021
    Inventors: Donald Johns, Judit Sovago
  • Publication number: 20200121679
    Abstract: The invention relates to the use of a H3R inverse agonist for the treatment of shift work disorder.
    Type: Application
    Filed: April 17, 2018
    Publication date: April 23, 2020
    Inventors: Donald Johns, Klaus KUCHER, Judit SOVAGO
  • Publication number: 20170348294
    Abstract: The invention concerns the use of certain alpha 7 nicotinic acetylcholine receptor agonist for the facilitation of emergence from general anesthesia.
    Type: Application
    Filed: August 25, 2017
    Publication date: December 7, 2017
    Inventors: Markus FENDT, Dominik FEUERBACH, Sjoerd Jehannes FINNEMA, Baltazar GOMEZ-MANCILLA, Christer HALLDIN, Donald JOHNS, Cristina LOPEZ-LOPEZ, Kevin Hall MCALLISTER, Judit SOVAGO, Markus WEISS
  • Publication number: 20150313884
    Abstract: The invention concerns the use of certain alpha 7 nicotinic acetylcholine receptor agonist for the facilitation of emergence from general anesthesia.
    Type: Application
    Filed: July 15, 2015
    Publication date: November 5, 2015
    Inventors: Markus FENDT, Dominik FEUERBACH, Sjoerd Johannes FINNEMA, Baltazar GOMEZ-MANCILLA, Christer HALLDIN, Donald JOHNS, Cristina LOPEZ-LOPEZ, Kevin Hall MCALLISTER, Judit SOVAGO, Markus WEISS